Literature DB >> 16870139

Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells.

Akinobu Maeda1, Koh-ichi Nakashiro, Shingo Hara, Toyokazu Sasaki, Yoshihiro Miwa, Nozomu Tanji, Masayoshi Yokoyama, Hiroyuki Hamakawa, Ryoichi Oyasu.   

Abstract

Clinical studies with prostate cancer tissue indicate that alterations in androgen receptor (AR) or c-Met overexpression are associated with androgen-independent progression. We investigated the interaction between AR and c-Met signaling in human prostate cancer cells. Androgen withdrawal or AR-specific small interfering RNA significantly reduced the growth rate while each maneuver induced the expression of c-Met. Knockdown of both AR and c-Met expression markedly inhibited the cell growth. Furthermore, microarray analysis indicated that the activation of c-Met down-regulated the expression of DNA repair-related genes including 8-oxoguanine DNA glycosylase. Exogenous hepatocyte growth factor also induced the production of intracellular reactive oxygen species and resulted in the accumulation of DNA damages. These results suggested that the activation of c-Met signaling may lead to induction of spontaneous mutations or genomic instability, which may lead to the progression of androgen-independent state. Thus, c-Met signaling is utilized for survival and growth under the androgen-depleted condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870139     DOI: 10.1016/j.bbrc.2006.07.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition.

Authors:  A Cannistraci; G Federici; A Addario; A L Di Pace; L Grassi; G Muto; D Collura; M Signore; L De Salvo; S Sentinelli; G Simone; M Costantini; S Nanni; A Farsetti; V Coppola; R De Maria; D Bonci
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

Review 2.  The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials.

Authors:  Andreas Varkaris; Paul G Corn; Sanchaika Gaur; Farshid Dayyani; Christopher J Logothetis; Gary E Gallick
Journal:  Expert Opin Investig Drugs       Date:  2011-10-28       Impact factor: 6.206

3.  Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis.

Authors:  Shoichiro Mukai; Kenji Yorita; Koji Yamasaki; Takahiro Nagai; Toyoharu Kamibeppu; Satoru Sugie; Kazutaka Kida; Chie Onizuka; Hiromasa Tsukino; Toshio Kamimura; Toshiyuki Kamoto; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2015-04-11       Impact factor: 4.174

4.  The PCa Tumor Microenvironment.

Authors:  Joseph L Sottnik; Jian Zhang; Jill A Macoska; Evan T Keller
Journal:  Cancer Microenviron       Date:  2011-07-05

Review 5.  MET and VEGF: synergistic targets in castration-resistant prostate cancer.

Authors:  D T Aftab; D M McDonald
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

6.  Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions.

Authors:  Jinlu Dai; Honglai Zhang; Andreas Karatsinides; Jill M Keller; Kenneth M Kozloff; Dana T Aftab; Frauke Schimmoller; Evan T Keller
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

7.  Efficacy of c-Met inhibitor for advanced prostate cancer.

Authors:  William H Tu; Chunfang Zhu; Curtis Clark; James G Christensen; Zijie Sun
Journal:  BMC Cancer       Date:  2010-10-14       Impact factor: 4.430

Review 8.  Stroma-epithelium crosstalk in prostate cancer.

Authors:  Yi-Nong Niu; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285

Review 9.  Cancer associated fibroblasts in cancer pathogenesis.

Authors:  Omar E Franco; Aubie K Shaw; Douglas W Strand; Simon W Hayward
Journal:  Semin Cell Dev Biol       Date:  2009-11-05       Impact factor: 7.727

10.  Semaphorin 4D signaling requires the recruitment of phospholipase C gamma into the plexin-B1 receptor complex.

Authors:  Jakub M Swiercz; Thomas Worzfeld; Stefan Offermanns
Journal:  Mol Cell Biol       Date:  2009-10-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.